We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Boom in Smart Pills Will Reach New Peaks

By HospiMedica International staff writers
Posted on 17 Mar 2014
Print article
The increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills. These are the latest findings of Frost & Sullivan (Frost; London, United Kingdom), an international market research firm.

Smart pills are widely used for gastrointestinal (GI) imaging, replacing invasive endoscopes. But while GI imaging sensing technologies have been successfully commercialized, other projected uses, such as drug delivery pills and surgical smart pills, have yet to be proven clinically. Commercialization preference and focus is currently on wireless capsule endoscopes and ingestible sensors for internal signs monitoring. In the future, advancements in smart pill enabling technologies, such as wireless communications, remote patient monitoring, and miniaturization, will further widen the range of smart pill applications.

Being a nascent market, there is a need to build confidence among patients, physicians, researchers, investors, and regulatory agencies. Measures such as strategic and business partnerships and scientific and clinical education will help win the trust of regulatory authorities, investors, and users. In addition, it is imperative that companies take advantage of the government funding available to universities and small businesses. This is especially vital owing to the uneven distribution of venture capital investment, which prevents start-up companies from developing into players.

An additional path to help start-up companies’ growth is partnering with laboratories that have access to funds for basic and applied sciences, to help secure financial support which can be leveraged into commercial products. In fact, government-sponsored research projects have given rise to formidable academia-industry research collaboration. Such research consortia are especially common in the European Union, resulting in successful spin-offs that commercialize technologies and further the scope of the smart pills.

“Smaller companies that cannot effectively translate a technology into a commercial product, can also explore licensing them to companies with established solutions in the market,” suggested Frost technical insights research analyst Bhargav Rajan. “Meanwhile, new market participants can rely on technology incubators to ease their technology towards commercialization.”

“The smart pills industry is likely to experience a burst of new products in the next five to seven years, offering tremendous potential for collaboration between the industry and academia,” added Mr. Rajan. “While overarching product designs developed by the industry can lead to breakthrough products such as capsule endoscopes, it is by leveraging ideas from basic and applied sciences at universities and research centers that product differentiation and value enhancement can be achieved.”

Related Links:

Frost & Sullivan


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Self-Driving Mobile C-arm
CIARTIC Move

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.